WallStreetZenWallStreetZen

NASDAQ: INDV
Indivior Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for INDV

Based on 2 analysts offering 12 month price targets for Indivior Pharmaceuticals Inc

Min Forecast
$46.00+15.58%
Avg Forecast
$47.00+18.09%
Max Forecast
$48.00+20.6%

Should I buy or sell INDV stock?

Based on 2 analysts offering ratings for Indivior Pharmaceuticals Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their INDV stock forecasts and price targets.

INDV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-18
lockedlocked$00.00+00.00%2026-01-12

1 of 1

Forecast return on equity

Is INDV forecast to generate an efficient return?

Company
-417.99%
Industry
47.11%
Market
174.26%
INDV's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INDV forecast to generate an efficient return on assets?

Company
50.28%
Industry
18.42%
INDV is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INDV earnings per share forecast

What is INDV's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$3.55+76.6%
Avg 2 year Forecast
$3.86+92.2%
Avg 3 year Forecast
$4.11+104.51%
INDV's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

INDV revenue forecast

What is INDV's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$1.3B-1.78%
Avg 2 year Forecast
$1.3B+2.79%
Avg 3 year Forecast
$1.4B+8.21%
INDV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

INDV earnings growth forecast

How is INDV forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
27.08%
Industry
14.28%
Market
34.17%
INDV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
INDV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
INDV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

INDV revenue growth forecast

How is INDV forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
2.62%
Industry
9.17%
Market
13.95%
INDV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
INDV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

INDV vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
INDV$39.80$47.00+18.09%Strong Buy
AMRX$17.15$17.33+1.07%Strong Buy
RGC$6.37N/AN/A
SUPN$48.05N/AN/A
LNTH$109.89$115.00+4.65%Strong Buy
View Top Pharmaceutical Stocks

Indivior Pharmaceuticals Stock Forecast FAQ

Is Indivior Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: INDV) stock is to Strong Buy INDV stock.

Out of 2 analysts, 1 (50%) are recommending INDV as a Strong Buy, 1 (50%) are recommending INDV as a Buy, 0 (0%) are recommending INDV as a Hold, 0 (0%) are recommending INDV as a Sell, and 0 (0%) are recommending INDV as a Strong Sell.

If you're new to stock investing, here's how to buy Indivior Pharmaceuticals stock.

What is INDV's earnings growth forecast for 2026-2028?

(NASDAQ: INDV) Indivior Pharmaceuticals's forecast annual earnings growth rate of 27.08% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 14.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.17%.

Indivior Pharmaceuticals's earnings in 2026 is $251,000,000.On average, 8 Wall Street analysts forecast INDV's earnings for 2026 to be $432,774,537, with the lowest INDV earnings forecast at $358,450,851, and the highest INDV earnings forecast at $518,473,552. On average, 8 Wall Street analysts forecast INDV's earnings for 2027 to be $471,021,487, with the lowest INDV earnings forecast at $399,075,280, and the highest INDV earnings forecast at $546,637,547.

In 2028, INDV is forecast to generate $501,172,812 in earnings, with the lowest earnings forecast at $415,802,987 and the highest earnings forecast at $588,883,540.

What is INDV's revenue growth forecast for 2026-2028?

(NASDAQ: INDV) Indivior Pharmaceuticals's forecast annual revenue growth rate of 2.62% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.95%.

Indivior Pharmaceuticals's revenue in 2026 is $1,291,000,000.On average, 8 Wall Street analysts forecast INDV's revenue for 2026 to be $154,597,169,544, with the lowest INDV revenue forecast at $138,259,613,772, and the highest INDV revenue forecast at $163,985,168,010. On average, 8 Wall Street analysts forecast INDV's revenue for 2027 to be $161,790,570,966, with the lowest INDV revenue forecast at $146,184,547,542, and the highest INDV revenue forecast at $171,788,179,722.

In 2028, INDV is forecast to generate $170,325,115,026 in revenue, with the lowest revenue forecast at $155,938,312,182 and the highest revenue forecast at $183,736,541,406.

What is INDV's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: INDV) forecast ROA is 50.28%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 18.42%.

What is INDV's Price Target?

According to 2 Wall Street analysts that have issued a 1 year INDV price target, the average INDV price target is $47.00, with the highest INDV stock price forecast at $48.00 and the lowest INDV stock price forecast at $46.00.

On average, Wall Street analysts predict that Indivior Pharmaceuticals's share price could reach $47.00 by Jun 18, 2027. The average Indivior Pharmaceuticals stock price prediction forecasts a potential upside of 18.09% from the current INDV share price of $39.80.

What is INDV's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: INDV) Indivior Pharmaceuticals's current Earnings Per Share (EPS) is $2.01. On average, analysts forecast that INDV's EPS will be $3.55 for 2026, with the lowest EPS forecast at $2.94, and the highest EPS forecast at $4.25. On average, analysts forecast that INDV's EPS will be $3.86 for 2027, with the lowest EPS forecast at $3.27, and the highest EPS forecast at $4.48. In 2028, INDV's EPS is forecast to hit $4.11 (min: $3.41, max: $4.83).

What is INDV's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: INDV) forecast ROE is -417.99%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.